Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Conference News TCT 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Yael L. Maxwell

October 28, 2025

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

Presentation TCT 2025

Effects of Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator as an Adjunct to Primary PCI in Patients with STEMI and Large Thrombus Burden: A Randomized, Double-Blind, Placebo-Controlled Trial

Presenter: Shamir R. Mehta

October 28, 2025

Presentation TCT 2024

Increasingly Complex ACS Patients: Culprit Only, Complete Percutaneous Revascularization or CABG?

Presenter: Shamir Mehta

October 29, 2024

Presentation TCT 2023

Complete Revascularization in Patients With STEMI and MVD: CV Outcomes, Quality of Life, and Future Directions

Presenter: Shamir Mehta

October 25, 2023

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

Presentation TCT 2022

STEMI and MVD Update on the Evidence: Rationale for COMPLETE 2

Presenter: Shamir Mehta

September 19, 2022

Presentation TCT 2022

Randomized, Double-Blind Trial of Routine Early Treatment With PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Presenter: Shamir Mehta

September 19, 2022

Presentation TCT 2019

Case #2: STEMI PCI In A Newly Diabetic Patient

Presenter: Shamir Mehta

September 28, 2019

Presentation TCT 2019

COMPLETE Trial: Focus on STEMI and MVD

Presenter: Shamir Mehta

September 26, 2019

Presentation TCT 2019

Complete Revascularization in STEMI with MVD (Without Shock): Is the Story COMPLETE?

Presenter: Shamir Mehta

September 26, 2019

Presentation TCT 2015

Multivessel PCI in STEMI: Focused Commentary

Presenter: Ajay J. Kirtane, E. Magnus Ohman, Cindy L. Grines, Shamir R. Mehta

October 13, 2015

Presentation TCT 2015

I Dont Believe Multivessel Revascularization Should Routinely Be Performed During the Index Primary PCI or Before Hospital Discharge!

Presenter: Nick Curzen, Ajay J. Kirtane, Shamir R. Mehta

October 12, 2015

Presentation TCT 2015

From PRAMI, CvLPRIT, and Other Studies to COMPLETE: What Answers Can We Expect (and Not Expect) From COMPLETE?

Presenter: Ori Ben-Yehuda, Ajay J. Kirtane, Shamir R. Mehta

October 11, 2015

Presentation TCT 2015

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

Presenter: Thomas Engstroem, Barry D. Rutherford, Shamir R. Mehta

October 11, 2015

Presentation TCT 2013

Optimal Management of Multivessel Disease in Patients Undergoing Primary PCI: Design and Rationale of the Multinational COMPLETE Trial

Presenter: Shamir Mehta

October 30, 2013

Presentation TCT 2012

STEMI Cocktails

Presenter: Shamir Mehta

October 24, 2012

Presentation TCT 2012

Clopidogrel Is Still the Choice for Most!

Presenter: Shamir Mehta

October 24, 2012

Presentation TCT 2012

Believe the Data! Radial Approach for Primary PCI Is Preferred!

Presenter: Shamir Mehta

October 23, 2012

Video

» Interview

Randomized, Double-Blind Trial of Routine Early Treatment with PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

September 18, 2022

Advertisement

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Effects of Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator as an Adjunct to Primary PCI in Patients with STEMI and Large Thrombus Burden: A Randomized, Double-Blind, Placebo-Controlled Trial

Increasingly Complex ACS Patients: Culprit Only, Complete Percutaneous Revascularization or CABG?

Complete Revascularization in Patients With STEMI and MVD: CV Outcomes, Quality of Life, and Future Directions

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

STEMI and MVD Update on the Evidence: Rationale for COMPLETE 2

Randomized, Double-Blind Trial of Routine Early Treatment With PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Case #2: STEMI PCI In A Newly Diabetic Patient

COMPLETE Trial: Focus on STEMI and MVD

Complete Revascularization in STEMI with MVD (Without Shock): Is the Story COMPLETE?

Multivessel PCI in STEMI: Focused Commentary

I Dont Believe Multivessel Revascularization Should Routinely Be Performed During the Index Primary PCI or Before Hospital Discharge!

From PRAMI, CvLPRIT, and Other Studies to COMPLETE: What Answers Can We Expect (and Not Expect) From COMPLETE?

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

Optimal Management of Multivessel Disease in Patients Undergoing Primary PCI: Design and Rationale of the Multinational COMPLETE Trial

STEMI Cocktails

Clopidogrel Is Still the Choice for Most!

Believe the Data! Radial Approach for Primary PCI Is Preferred!

Randomized, Double-Blind Trial of Routine Early Treatment with PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content